• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Questcor

Anonymous board for Questcor
Replies
9
Views
8K
anonymous
Replies
69
Views
30K
anonymous
Replies
51
Views
22K
anonymous
Replies
6
Views
4K
anonymous
Replies
7
Views
4K
anonymous
Replies
24
Views
16K
anonymous
Replies
62
Views
24K
anonymous
Replies
6
Views
4K
anonymous
Replies
0
Views
3K
anonymous
Replies
45
Views
13K
anonymous
Replies
1
Views
2K
Flay-ling
Replies
5
Views
2K
anonymous
Replies
4
Views
3K
anonymous
Replies
18
Views
6K
anonymous